Ancillary Tests of Brain Death
Most ancillary tests of brain death can be divided into those that assess brain electrical activity and those that measure cerebral blood flow. Those that assess brain electrical activity include electroencephalography (EEG) and somatosensory evoked potentials (SEP). EEG is the most widely used test to confirm brain death. A properly performed EEG demonstrating an isoelectric trace, in the absence of several conditions also known to cause a similar pattern, is highly reliable in confirming brain death. When an EEG can not be properly performed or other conditions can not be ruled out, tests of cerebral blood flow can be useful.
Contrast Angiography
Absence of blood flow to the brain leads to destruction of brain tissue. A number of imaging techniques have been described which can measure cerebral blood flow and therefore have the potential to confirm brain death. Failure to opacify the intracranial vessels during conventional or digital subtraction (intravenous and intra-arterial) cerebral angiography has long been considered the gold standard for confirming the diagnosis of brain death 4 -19 • Subintimal injection of contrast or arterial thrombosis can mimic lack of blood flow in the artery being injected but this is unlikely to occur in both carotids and vertebrals. Contrast can be artifactually introduced into the intracranial circulation if it is injected too vigorously during angiography. For this reason, some have recommended intravenous vena caval or aortic arch injections rather than selective intraarterial injections. Contrast can also reach the intracranial vessels if the head is in a dependent position. Some have expressed concerns that contrast can cause the final cessation of blood flow in a few remaining vessels or can damage transplantable kidneys in brain-dead donors. There is also increased risk to these patients associated with transport to the angiographic suite.
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Radionuclide Angiography
Confirmation of brain death by radionuclide angiographic demonstration of absent cerebral blood flow has been recommended for several years7.9.11.20-38. The test has been found to be reliable, safe and expeditious, and can be performed at the bedside.
For many years, the radionuclide agents of choice for radionuclide angiography were blood pool agents including Tc-99m pertechnetate, Tc-99m diethylenetriaminepenta-acetic acid (DTPA), and Tc-99m glucoheptonate which do not cross the blood-brain barrier. These agents are injected intravenously as a bolus while imaging is performed over the head with a gamma camera for about 15 minutes. No intra-arterial flow confirms the clinical diagnosis of brain death. An inadequate bolus or gamma camera malfunction during the radionuclide injection makes the study uninterpretable.
Several concerns have been raised over the use of radionuclide angiography with blood pool agents for Anaesthesia and Intensive Care. Vol. 23 . No. I. February. 1995 the determination of brain death. These agents are not reliable indicators of posterior fossa and brainstem blood flow. This should not, however, be an issue when taken in the clinical context of brainstem areflexia. Theoretical uncertainty of brain death may arise from persistent filling of venous sinuses: however, it has been shown that absence of intracranial flow with or without sinus opacification is still predictive of brain death7.2J.31,J9-41. False negative studies have been reported in the presence of an open skull fracture 42 and after placement of a ventricular shunt tube 43 . This is thought to be due to a decrease in intracranial pressure with resultant restoration of cerebral perfusion pressure even in the presence of neuronal death. Problems of interpretation can occur when CBF is severely reduced but not absent, in some patients with haematomas or tumours 44 and when there is jugular venous reflux.
In recent years, cerebral perfusion agents Tc-99m hexamethylpropylene-amine oxime (HMPAO) or 1-123 iodoamphetamine (IMP) which cross the blood brain barrier have been recommended instead of blood pool agents for the confirmation of brain death 37 ,38,40,44-56, Since these agents are picked up and held by functioning brain cells for several hours, studies are easier to interpret and are less dependent on imaging technique than with blood pool agents. Suboptimal bolus injections of the agent or temporary equipment malfunctions during injection do not hinder interpretations. Delayed imaging can be performed in more than one plane. They can theoretically detect lower degrees of CBF than blood pool agents because they are taken up by viable brain tissue. In contrast, with widespread neuronal death, uptake of these agents is absent even when artifactual cerebral per fusion pressure is maintained. Since these agents have a ubiquitous distribution throughout the body, directly related to cardiac output and regional tissue perfusion, the viability of other transplantable organs can be determined.
Radionuclide cerebral perfusion agents can be coupled with single photon emission computed tomography (SPECT) to confirm the diagnosis of brain death 52 ,57,58. This allows much more precise regional information including whether or not there is preservation of blood flow to the posterior fossa and brainstem.
Ultrasound
Much has been written about the use of echoencephalography, carotid Doppler and most recently transcranial Doppler ultrasound (TCD) in confirming brain death 19,59-83. Characteristic findings of brain death due to intracranial circulatory arrest with TCD include oscillating movement of the blood column within the arteries, short systolic spikes, and absence of signal when previously found. TCD has the advantage of being noninvasive, portable, quick, and of relatively low cost. Specificity and sensitivity have been shown to be as high as 1000/0 and 91 % respectively. In order to minimize the number of false positives, the anterior and posterior circulations must be studied in both hemispheres.
Computed Tomography
Dynamic computed tomography (CT) has been recommended as a confirmatory test of brain death 10,16,84-86 .. Dynamic CT has the advantage of also being able to demonstrate underlying intracranial pathology which may account for a patient's coma, such as brain tumors, haematomas, swelling and necrosis.
An initial CT is performed without contrast. This is followed by a CT scan after the intravenous administration of a bolus of iodinated contrast. In patients with brain death, there is no identifiable increase in attenuation of brain parenchyma after injection of contrast. Furthermore, there is no significant opacification of the arteries of the circle of Willis. In order to assure that there was an adequate bolus of contrast, enhancement of extracranial soft tissue, cervical great vessels or the kidneys should be identified.
Xenon computed tomographic measurement of CBF has also been recommended for confirmation of brain death 87 -91 . This technique has the advantage of providing diagnostic anatomical and regional quantitative CBF information during the same examination. Minimal (less than 1-5 mI/100g/min) or absent CBF is indicative of brain death.
Magnetic Resonance Imaging
Magnetic resonance imaging with blood flow sensitive techniques 92 ,93 has been described for confirming the diagnosis of brain death. Inability to detect blood flow in cerebral vessels or molecular motion in brain parenchyma is probably indicative of brain death, although little research has been done in this area. Magnetic resonance imaging, similar to CT, also has the advantage of demonstrating the anatomical aetiology for a person's coma.
Phosphorus 93 -96 and proton 94 magnetic resonance spectroscopy has recently been described in the setting of brain death. Total absence of ATP and high inorganic phosphorus is indicative of brain death with p31 phosphorus spectroscopy. Brian death is characterized by high levels of lactate and choline and decreased levels of n-acetyl aspartate (NAA) with proton spectroscopy. It appears that these phosphorus and proton spectroscopy abnormalities become clearly abnormal rather late in brain death.
Positron Emission Tomography
There have been two reports of the use of positron emission tomography in the setting of brain death. One of these reports describes the absence of detectable glucose metabolism in patients with brain death 97 • Other investigators have reported preserved glucose metabolism in a patient with documented brain death. Like phosphorus magnetic resonance spectroscopy, early in the course of brain death glucose metabolism is still probably preserved in some degree. Some of this may be due to glial cells, which are more resilient than neurones, maintaining some glucose metabolism after widespread neuronal death. CONCLUSION Clinical examination is usually sufficient for making the diagnosis of brain death. Confirmatory tests are infrequently necessary to confirm the diagnosis of brain death. This is particularly true when the aetiology of the patient's demise is not clear, when various metabolic disorders are present, and in children. These imaging tests should also be of value in making earlier determinations of brain death so that transplant organ viability will be optimized and medical care costs minimized.
